Astermark J, Ranta S, Myrin-Westesson L, Hoffmann M, Quere S, Sanchez AYC, Robson S, Czirok T, Lassila R, Holme PA (2025)
Health-Related Quality of Life, Physical Activity and Joint Health in People With Severe Haemophilia A Receiving Emicizumab: Results From the Phase IV HemiNorth 2 Study
Haemophilia (in press)
DOI 10.1111/hae.70121, PubMed 40898745

Holme PA, Poulsen LH, Tueckmantel C, Maas Enriquez M, Alvarez Román MT, De Cristofaro R (2025)
Safety and Efficacy of Damoctocog Alfa Pegol Prophylaxis in Patients With Severe Haemophilia A: Results of an Interventional, Post-Marketing Study
Haemophilia (in press)
DOI 10.1111/hae.70099, PubMed 40838268

Tsykunova G, Holme PA, Tran HTT, Frederiksen H, Tjonnfjord E, Munthe LA, Drivet E, Kared H, Sørvoll IH, Ahlen MT, Mahevas M, Michel M, Bussel JB, Kuter DJ, Tvedt THA, Ghanima W (2025)
Safety and Efficacy of Daratumumab in Immune Thrombocytopenia
Blood Adv (in press)
DOI 10.1182/bloodadvances.2025017279, PubMed 40763272